dromostanolone (drostanolone)

Subscribe to Selected New Research on dromostanolone

5 relevant articles (0 outcomes, 1 trials/studies) found for this Bio-Agent

Description: synthetic anabolic androgenic steroid used to lower plasma cholesterol & as antineoplastic agent in advanced breast neoplasms; major descriptor (66-86); on-line search ANDROSTANOLS (80-86); ANDROSTANES (68-86); INDEX MEDICUS search DROMOSTANOLONE (66-86); RN given refers to (2alpha,5alpha,17beta)-isomer

Also Known As:

drostanolone; 17 beta-hydroxy-2 alpha-methyl-5 alpha-androstan-3-one; dromostanolone, (5alpha,17beta)-isomer; drostanolon; methalone; prometholone

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/31/1969 - "Drostanolone and norethisterone in disseminated breast cancer." 01/01/1975 - "Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study." 08/01/1978 - "In 91 patients with advanced breast cancer testololactone, drostanolone, and nandrolone were compared in a controlled clinical trial" 01/01/1975 - "It can be said that a single hormone therapy with testosterone decanoate, drostanolone, and testosterone gave similar rates of objective responses in metastatic breast cancer" 12/30/1982 - "Among fifty patients with bone metastases from breast cancer who were hospitalized between 1971 and 1980, 19 were given intermittent chemotherapy including both hormone-therapy (drostanolon propionate and tamoxifen) and a combination of cyclophosphamide, methotrexate, 5 FU, doxorubicin and vincristine (CMFDV)" Get all the results and reference details, order at left...
2.	Hypertriglyceridemia 09/01/1974 - "Hypertriglyceridemia in hemodialysis patients during oral dromostanolone therapy for anemia." Get all the results and reference details, order at left...
3.	Neoplasm Metastasis (Metastasis) 12/30/1982 - "Among fifty patients with bone metastases from breast cancer who were hospitalized between 1971 and 1980, 19 were given intermittent chemotherapy including both hormone-therapy (drostanolon propionate and tamoxifen) and a combination of cyclophosphamide, methotrexate, 5 FU, doxorubicin and vincristine (CMFDV)" Get all the results and reference details, order at left...
4.	Anemia 09/01/1974 - "Hypertriglyceridemia in hemodialysis patients during oral dromostanolone therapy for anemia." Get all the results and reference details, order at left...
4 Diseases and 5 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	testololactone
2.	testosterone decanoate
3.	Hormones
4.	Vincristine (Oncovin)
5.	Testosterone (Sustanon)
6.	Tamoxifen
7.	Norethindrone (Norethisterone)
8.	Nandrolone (Nortestosterone)
9.	Methotrexate (Mexate)
10.	Doxorubicin (Adriamycin)
11 Drugs and Important Bio-Agents and 4 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Renal Dialysis (Hemodialysis)
2.	Drug Therapy (Chemotherapy)
2 Therapies and Procedures and 2 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>